Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Danger in the Nail: Malignant Onychopapilloma

Description

The presentation discusses the concept of malignant onychopapilloma, highlighting its evolution from being considered a benign lesion to recognizing atypical variants that may exhibit malignant characteristics. An instructive case involving a 70-year-old male with an asymptomatic lesion on his left middle finger for two years is presented. The lesion demonstrated a combination of red and yellow colors, splinter hemorrhages, hyperkeratosis, and thinning of the nail plate upon examination. Histopathological analysis showed atypical onychocytes and areas of acanthosis without HPV staining, differentiating it from other nail conditions such as onychocytic carcinoma or Bowen's disease. The speaker emphasizes the recent identification of atypical onychopapillomas, which were asymptomatic and pigmented, and underlines the importance of markers like Ki-67 and P53 in assessing these lesions. The discussion integrates newer research findings and invites future participation in advanced nail histopathology workshops, reinforcing the need for continued exploration of these complex nail pathologies.

View more

Conclusions

  • Malignant onychopapilloma is a newly recognized entity that can present similarly to benign onychopapillomas but requires careful evaluation due to atypical features.
  • Histopathology plays a crucial role in distinguishing malignant onychopapillomas from benign variants, showing atypias such as full-thickness dysplasia.
  • Atypical variants of onychopapilloma, while rare, should be recognized as potential malignancies, emphasizing the need for thorough examination of nail lesions.
  • Clinical signs of malignant onychopapillomas may include unusual pigmentation and changes in nail structure that warrant further investigation.
  • The use of immunohistochemical markers like Ki-67 and p53 could aid in identifying atypical cases but should be interpreted with caution as their presence does not confirm malignancy.
  • Gabutti M, Lorizzo M, Beltraminelli H. Malignant onychopapilloma. Wileys, Department of Dermatology, Inselspital, University of Bern, Bern, Switzerland.
  • André J, Ewbank A, Moulonguet I, Richert B. Three atypical/malignant onychopapillomas in a 52-case series with immunohistochemical study. J Cutan Pathol. 2024 Mar;51(3):239-245. doi: 10.1111/cup.14558. Epub 2023 Nov 6. PMID: 37932936.